miR451 and AMPK Mutual Antagonism in Glioma Cell Migration and Proliferation: A Mathematical Model by Kim, Yangjin et al.
miR451 and AMPK Mutual Antagonism in Glioma Cell
Migration and Proliferation: A Mathematical Model
Yangjin Kim
1*, Soyeon Roh
2, Sean Lawler
3, Avner Friedman
4
1Department of Mathematics and Statistics, University of Michigan, Dearborn, Michigan, United States of America, 2Department of Natural Sciences, University of
Michigan, Dearborn, Michigan, United States of America, 3Translational Neuro-Oncology Group, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United
Kingdom, 4Mathematical Biosciences Institute, Ohio State University, Columbus, Ohio, United States of America
Abstract
Glioblastoma multiforme (GBM) is the most common and the most aggressive type of brain cancer; the median survival time
from the time of diagnosis is approximately one year. GBM is characterized by the hallmarks of rapid proliferation and
aggressive invasion. miR-451 is known to play a key role in glioblastoma by modulating the balance of active proliferation
and invasion in response to metabolic stress in the microenvironment. The present paper develops a mathematical model
of GBM evolution which focuses on the relative balance of growth and invasion. In the present work we represent the miR-
451/AMPK pathway by a simple model and show how the effects of glucose on cells need to be ‘‘refined’’ by taking into
account the recent history of glucose variations. The simulations show how variations in glucose significantly affect the level
of miR-451 and, in turn, cell migration. The model predicts that oscillations in the levels of glucose increase the growth of
the primary tumor. The model also suggests that drugs which upregulate miR-451, or block other components of the
CAB39/AMPK pathway, will slow down glioma cell migration. The model provides an explanation for the growth-invasion
cycling patterns of glioma cells in response to high/low glucose uptake in microenvironment in vitro, and suggests new
targets for drugs, associated with miR-451 upregulation.
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Introduction
Glioblastoma is the most common and aggressive brain
tumour, marked by high levels of proliferation angiogenesis and
invasion [1]. These tumors are highly invasive and the median
survival time from the time of diagnosis is approximately one
year. Tumor cells may face hypoxia, acidity, and limited nutrient
availability as they grow. In order to maintain rapid growth,
glioblastoma cells must remain highly adaptive in response to
changes in the microenvironment [2]. To enable rapid prolifer-
ation, cancer cells shift their metabolic machinary toward high
levels of glucose uptake and lactate production (the ‘‘Warburg
Effect’’) [3,4]. While differentiated cells favor oxidative phos-
phorylation and anaerobic glycolysis, proliferative tumor cells
adapt what appears to be a less effective way of metabolism, i.e.,
aerobic glycolysis [5]; see Figure 1. While the tricarboxylic acid
(TCA), or Krebs, cycle (schematically described by the pathway
in Figure 1) is a key step for generating ATP in nonhypoxic
normal cells, cancerous cells consume large amounts of glucose
and generate lactic acid rather than using the TCA cycle [4].
Cancer cells ensure an adequate glucose supply through
increased angiogenesis and migration [2] and cellular responses
to glucose withdrawal may be critical for the survival of cancer
cells in rapidly growing tumors such as glioblastoma, where
glucose levels may fluctuate. Cancer cells therefore engage
strategies of metabolic adaptation to survive periods of metabolic
stress and maintain viability as cells accumulate [6]. The 59-
adenosine monophosphate activated protein kinase (AMPK)
pathway is the major cellular sensor of energy availability [7].
AMPK is a conserved cellular energy sensor that is activated by
metabolic stress to promote energy conservation and glucose
uptake [7]. This allows cells to adapt to periods of low energy
availability, thus avoiding bioenergetic catastrophe and cell
death.
In addition to rapid proliferation, invasion of glioma cells from
the core tumor into the surrounding brain tissue is a major reason
for treatment failure: the migrating cells are not eliminated in
surgical resection and promote tumor recurrence. Godlewski et al.
[2] have recently identified a novel mechanism in which glioma
cell survival, motility and proliferation are coordinately regulated
by a single microRNA (miR-451) that regulates AMPK signaling
in response to glucose levels in glioblastoma cells. Their model is
shown schematically in Figure 2. In this study, miR-451 was
shown to play a key role in glioblastoma by modulating the
balance of active proliferation and invasion in response to
metabolic stress in the microenvironment. Normal glucose levels
allow high miR-451 which in turn leads to elevated proliferation
and decreased cell migration, whereas the low glucose level
downregulates miR-451 thereby leading to enhanced cell motility
and migration.
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28293Kim et al. [8] recently developed a mathematical model of
invasive glioma cells in 3D tumor spheroids. The model was shown
to be capable of reproducing migration patterns of glioma cells in in
vitro experiments, exhibiting, inparticular, dispersion and branching
of cells. The model included MMPactivity and glucose levelsas well
as chemotaxis, haptotaxis and cell-cell adhesion forces. The rapid
migration of cells is caused primarily by the chemotaxis forces that
are associated with glucose concentration G.
In the present paper we explore in more detail the effect of glucose
on glioma cell behavior with the aim of suggesting drug targets that
will slow cell migration. In the present work we represent the miR-
451/AMPK pathway by a simple model and show how the effects of
glucose on cells need to be ‘‘refined’’ by taking into account the recent
history of glucose variations. We simulate the model of Kim et al. [8],
taking the glucose input to vary periodically. The simulations show
how variations in glucose significantly affect the level of miR-451 and,
in turn, cell migration. Importantly, the model predicts that
oscillations in the levels of glucose increase the growth of the primary
tumor. The model also suggests that drugs which upregulate miR-451,
or block other components of the CAB39/AMPK pathway, will slow
down glioma cell migration.
Materials and Methods
Mathematical modeling of miR-451-AMPK control
In order to incorporate the signaling network shown in Figure 2
into our model of glioma cell migration, we began by simplifying
this network. We represent by M and A the activities of miR-451
and AMPK complex, respectively. We also denote the signaling
pathways to miR-451 and AMPK complex, by G (glucose) and S
respectively. Figure 3, with protein degradation at rates m1 and m2
(for M and A), is a simplified representation of Figure 2. The
scheme includes autocatalytic activities of M and A as reported in
[2] and the inhibiting signal suggested in Figure 2A.
To mathematically model the dynamic network shown in
Figure 3 we introduce the following variables:
M(t)=concentration of miR-451 at time t,
A(t)=concentration of the complex CAB39/LKB1/
AMPK at time t,
S=source of the complex A,
G=glucose input level,
a=inhibition strength of miR-451 by the complex,
b=inhibition strength of the complex A by miR-451,
k1 =autocatalytic enhancement rate of miR-451
k2 =autocatalytic enhancement rate of the complex.
We associate to the network in Figure 3 the dynamical system,
written in dimensionless form,
dM
Lt
~Gz
k1k2
2
k2
2zaA2 {M, ð1Þ
Figure 1. Schematics of oxidative phosphorylation, anaerobic glycolysis, and aerobic glycolysis. (A) To enable rapid proliferation, cancer
cells shift their metabolic machinary toward high levels of glucose uptake and lactate production (aerobic glycolysis, the Warburg Effect’’). (B)
Differentiated cells favor oxidative phosphorylation and anaerobic glycolysis.
doi:10.1371/journal.pone.0028293.g001
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dA
dt
~Sz
k3k2
4
k2
4zbM2 {A: ð2Þ
Table 1 summarizes the parameters used in equations (1)–(2), and
some explanations are given in the Text S1. The strength of the
inhibition of miR-451 by the complex A can be controlled through
the dimensionless parameter a, and the strength of the inhibition
of the complex A by miR-451 can be controlled through the
dimensionless parameter b. The parameter E is given by m1=m2, the
ratio of the degradation rates of M and A, respectively. Since
miR-451 degrades much faster than the complex A, E is a very
small number (we shall take E=0.02). We recall (see Figure 2) that
elevated levels of miR-451 imply elevated cell proliferation and
reduced migration, whereas low levels of miR-451 imply reduced
cell proliferation and increased migration. In order to incorporate
the effect of glucose into our model of glioma cell migration, we
need to determine how the level of glucose G affects the level of
M.
When the main miR-451-AMPK system (1)–(2) is in equilibri-
um, we can solve miR-451 levels (M) as a function of injected
glucose amounts (G) for any set of parameters S,ki,a,b. Figure 4
shows the graph M~M(G) as S-shaped curve when the
parameter values are k1~4:0,k2~1:0,a~1:6,k3~4:0,k4~1:0,
b~1:0,S~0:2,E~0:02. The upper and lower branches are stable,
and the middle branch is unstable. If G is small, then the system
(1)–(2) is in the lower branch, M is low, and the glioma cells are in
migratory phase. This situation continues to hold as G is increased
until it reaches the value 0.6. At this point, the system jumps to the
high branch, with an elevated level of miR-451, and the cells are in
the proliferative phase (while migration is reduced). As G is
decreased, the level of miR-451 remains elevated, until G is
decreased to the level 0.4, at which time miR-451 jumps to the
lower branch, and the cells return to the migratory phase. We
conclude that the effect of glucose is history dependent: when G is
at an intermediate level, 0:4vGv0:6, the cells are in the
migratory phase if G was in increasing mode, and in the
proliferative phase if G was in decreasing mode.
Figure 4 suggests that a state (G,M) with M~2:0 will be moved
by the dynamical system (1)–(2) into the upper stable steady state
branch, resulting in overexpression of miR-451 and, thus, in
growth. On the other hand, if Mv2:0, then (G,M) will end up in
the lower stable state branch, which implies migration. Hence we
shall define the migratory region by MvthM and the prolifera-
tion/growth region by MwthM and take the threshold thM~2:0.
In the next section we shall incorporate this phenomenon into
the model which was developed in Kim et al. [8]. We conclude this
section by comparing predictions of the model (1)–(2) with
experimental results of Godlewski et al. [2]. In the experiments,
the miR-451 level was reduced by 80% when cells were cultured in
Figure 2. Proposed role of miR-451 in the regulation of LKB1 signaling in response to fluctuating glucose. miR-451 levels determine
cell migration or proliferation in response to glucose (blue triangle on the left). (A) Low glucose level reduces miR-451 and leads to upregulation of
AMPK and enhanced cell motility. (B) Normal glucose level upregulates miR-451, which in turn leads to increased proliferation and decreased cell
migration by inhibiting CAB39-LKB1-AMPK pathway. Schematic components of miR-451 and the CAB39/LKB1/AMPK complex is represented by
modules ‘M’ (box with red dotted line) and ‘A’ (box with blue dotted line) in our theoretical framework. Blue arrows on the right indicate the
switching behavior between a migratory mode in (A) and the proliferative state in (B) in response to fluctuating glucose.
doi:10.1371/journal.pone.0028293.g002
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simulation results, shown in Figure 5, are in good agreement with
these experimental results. Indeed, with the parameter set as in
Figure 4, the model predicts slightly more than 80% reduction of
miR-451 levels in low glucose.
Mathematical model of the complete dynamics
In [8] we previously developed a mathematical model of
migration patterns of glioma cells. The model included the forces
of cell-cell adhesion, haptotaxis, chemotaxis induced by a glucose
gradient,andsheddingofgliomacellsfromaspheroidgliomatumor.
Inthepresentpaperouraimistoexamine inmoredetailtheeffectof
glucose on cell migration. In order to elucidate the dependence of
gliomacellmigrationonthegradientofglucoseG,weshallvaryG in
a periodic manner at a location away from the primary tumor and
determine how these changes affect the proliferative and migratory
phasesofthe cells.Indoingsowe mayignorethe shedding ofcells,as
this will not affect how fast cells migrate after they leave the primary
tumor. We may also ignore the cell-cell adhesion, since this force
only affects the clumping pattern of cells, not their proliferation rate
or speed of migration. Thus in order to describe the effect of G-
oscillation on migratory/proliferative phases of glioma cells, we
ignore shedding and cell-cell adhesion, but include haptotaxis and
chemotaxis. On the other hand we shall incorporate the observation
(modeled by (1)–(2)) that tumor cells react to miR-451 expression in
response to the glucose level.
Table 1. Parameters that are used in the internal dynamics
model (miR-451/AMPK system).
Description Value Refs
k1 miR451 autocatalytic production rate 4.0 TW
k2 Inhibition parameter of miR-451
by AMPK complex
1.0 TW
a Inhibition strength of miR-451
by AMPK complex
1.6 TW
k3 AMPK autocatalytic production rate 4.0 TW
k4 Inhibition parameter of AMPK
complex by miR-451
1.0 TW
b Inhibition strength of AMPK
complex by miR-451
1.0 TW
S Signaling source of AMPK complex 0.2 TW
E Scaling factor (slow dynamics) 0.02 [12–14],TW
thM Threshold value of miR-451 for
the invasion/growth switch
2.0 TW
TW=This work.
doi:10.1371/journal.pone.0028293.t001
Figure 3. A simplified model of the network shown in Figure 2.
Two key molecules, miR-451 and AMPK complex, are represented by M
and A respectively. The dynamics of miR451 includes input from
glucose (G), decay (m1), and autocatalytic increase. AMPK complex is
induced by source (S), and undergoes autocatalytic increase with
natural decay (m2). In addition, there are mutual inhibition mechanisms
between M and A.
doi:10.1371/journal.pone.0028293.g003
Figure 4. The M{G hysteresis loop: M is upregulated when G
varies in the upper stable branch, and downregulated when G
varies in the lower stable branch. We define the migration region
by MvthM and the proliferation region by MwthM, and take
thM~2:0.
doi:10.1371/journal.pone.0028293.g004
Figure 5. Experiments vs. simulation. Effect of glucose deprivation
on miR-451 expression levels. In [2], miR-451 level was reduced by 21%
for different cell lines (U251, LN229) after cells are cultured for 24 hr in
normal (+, glucose 4:5g=l or reduced glucose (2, glucose 0.3 g/l).
Simulation results (red) are in good agreement with experimental
results (blue; U251 cell line) from [2]. Y-axis in the figure is the relative
miR-451 concentration for high (glucose+; dimensionless value G~0:7
in simulation) and low (glucose2, glucose2, G~0:4 in simulation) level
of glucose in the medium.
doi:10.1371/journal.pone.0028293.g005
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oscillations is schematically captured by Figure 6: The same total
amount of glucose, if injected in a fluctuating fashion, would lead
to increased tumor growth.
Tumor cell density ~n(x,t)Þ ð
As noted in the previous Section, tumor cells begin to invade the
surrounding environment when miR-451 levels are low and
AMPK activity is high, and they proliferate when miR-451 levels
are high and AMPK activity is low. This alternating behavior
between migration and proliferation under the control of miR-451
is modeled using a threshold of miR-451 level, thM, by the
following equation
Ln
Lt
~{(+:Jn)IMvthM |ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
Migration
zPnIMwthM |ﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄ}
Proliferation
, ð3Þ
where Jn is the flux of the cells under the migration mode, Pn is the
proliferation term under the growth mode, and IMwthM and
IMvthM are indicator functions. They are discontinuous but made
smooth in simulations.
The flux for movement consists of three components: random
motility (Jm), chemotaxis (Jc), and haptotaxis (Jh).
Jn~JmzJczJh~{ Dn+n |ﬄﬄﬄﬄ{zﬄﬄﬄﬄ}
Random motility
z
(xn
n+G
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1zlGj+Gj
2
q )
|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
Chemotaxis
z(x1
n
n+r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1zlrj+rj
2
q )
|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
Haptotaxis
, ð4Þ
where Dn is the random motility, xn is the chemotactic sensitivity,
x1
n is the haptotactic coefficient, and lG and lr are chemotactic
and haptotactic parameters respectively. Pn represents a logistic
growth under proliferation mode:
Pn~l11n(1{n=n0):
ECM ~r(x,t) ðÞ
ECM is degraded by MMP and undergoes remodeling/
reconstruction,
Lr
Lt
~{l21Przl22r(1{r=r0), ð5Þ
where l21 is the ECM degradation rate by MMP, l22 is the
reconstruction parameter, and r0 is the ECM carrying capacity.
MMP ~P(x,t) ðÞ
MMP is produced by invasive tumor cells in the presence of the
ECM and is usually localized near the invading cell front (small
diffusion),
LP
Lt
~DPDPzl31nr{l32P, ð6Þ
where DP is the diffusion coefficient, l31 is MMP production by
tumor cells (n), and l32 is the natural decay rate.
Glucose (~G(x,t))
To define the oscillation of the glucose supply, we denote by V a
region which includes all the glioma cells, and by Vd a subregion
Figure 6. Two different growth schemes of tumor spheroids (gray filled circle) with same initial size in response to fluctuating and
steady glucose (green solid line). (A) Cycle of growth and invasion in response to fluctuating glucose. Tumor cells (blue filled circle) at the surface
of the spheroid begin to migrate away from the core when miR-451 levels are low (blue solid line; high AMPK activity) due to low glucose. These
migratory cells become proliferative cells when high glucose is introduced and miR-451 levels are high (red solid line; low AMPK activity). (B)
Monotonic growth due to steady supply of glucose; the total supply of glucose is the same as in (A). We hypothesize that tumor spheroids with
fluctuating glucose in (A) will grow faster than ones grown in steady glucose supply in (B).
doi:10.1371/journal.pone.0028293.g006
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choose discrete times tj(1ƒjƒN) with a period of t (that is,
tj{tj{1~t for all j) and introduce the indicator functions
Ij(x,t)~ 1 if x[Vd,tjƒtƒtjzd
0
0 otherwise
(
ð7Þ
where N is the number of injections that take place during
intervals tjvtvtjzd
0
(d
0
vt). We assume that the concentration
of glucose (G) satisfies a reaction-diffusion equation on the whole
domain V:
LG
Lt
~DGDG |ﬄﬄﬄ{zﬄﬄﬄ}
Diffusion
{ l41nG |ﬄﬄ{zﬄﬄ}
Consumption
z
X N
j~1
l42Ij
|ﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄ}
Supply
, ð8Þ
where DG is the diffusion coefficient, l41 is the consumption rate of
glucose by tumor cells, and the last term is the glucose supply rate
from the far away field.
miR-451 ~M(x,t) ðÞ and AMPK ~A(x,t) ðÞ
The two internal key variables M,A (miR-451 and AMPK) for
the control of growth and invasion at each tumor cell are linked to
tumor cell density above (n):
LM
Lt
~(Gz
k1k2
2
k2
2zaA2 {M)
n
n0
, ð9Þ
E
LA
Lt
~(Sz
k3k2
4
k2
4zbM2 {A)
n
n0
: ð10Þ
Governing equations
Collecting the equations derived above for the tumor density
(n(x,t)), concentrations of the ECM (r(x,t)), MMP (P(x,t)),
glucose (G(x,t)), miR-451 (M(x,t)), and AMPK (A(x,t)), we have
Ln
Lt
~½DnDn{+:(xn
n+G
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1zlGj+Gj
2
q ){+:(x1
n
n+r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1zlrj+rj
2
q ) IMvthM
zl11n(1{n=n0)IMwthM,
ð11Þ
Lr
Lt
~{l21Przl22r(1{r=r0), ð12Þ
LP
Lt
~DPDPzl31nr{l32P, ð13Þ
LG
Lt
~DGDG{l41nGz
X N{1
j~0
l42Ij, ð14Þ
LM
Lt
~(Gz
k1k2
2
k2
2zaA2 {M)
n
n0
, ð15Þ
E
LA
Lt
~(Sz
k3k2
4
k2
4zbM2 {A)
n
n0
, ð16Þ
where IMwthM is the indicator function of growth region (where
miR-451 level (M) is greater than a threshold value (thM)) and
IMvthM is the indicator function of the invasive region (where
miR-451 level is below the threshold (thM)) .
The parameter values and the reference values for equations
(11)–(14) are given in Tables 2 and 3, respectively. Some of the
parameters are taken from the literature and others are estimated.
Text S1 explains the choice of the parameters and reference
values, and the non-dimensionalization scheme.
All the simulations in the Results section were performed using
a finite volume method and clawpack (http://www.amath.
washington.edu/,claw/) with a fractional step method [9] as
well as the non-linear solver nksol for algebraic systems. Equations
(11)–(16) were solved on a regular uniform spatial grid (hx =0.01).
An initial time step of dt~0:0001 was used, but adaptive time
stepping based on the number of iterations did increase or
decrease this step size.
Results
Key control system : miR-451-AMPK network
Consider a spherical brain tissue, jxjvR, with glioblastoma
tumor occupying a sphere jxjvR0 and glucose source at
R{dvjxjvR(R{dwR0). Glucose is consumed by tumor cells,
resulting in low glucose concentrations near jxj~R0 and relatively
high glucose concentrations near the far field jxj~R. This creates
a gradient field of glucose. Under this microenvironmental
condition, the glioblastoma cells tend to migrate toward the
glucose rich region, i.e., towards the far field, jxj~R. Indeed,
glioblastoma cells are known for their particular tendency to
metabolize glucose, through aerobic glycolysis, called the Warburg
effect; recall Figure 1. Furthermore, the cells in the tumor core,
starving and accumulating toxic waste materials, are sending
‘escape’ messages through hand-hand signaling toward the cells at
the surface jxj~R0 of the tumor, further encouraging them to
invade into the far field. In our model low levels of miR-451 (high
level of AMPK activity) due to low glucose levels at cell sites trigger
tumor cells to initiate invasion toward jxj~R, and keep invading
until the miR-451 level creeps above a threshold (thM~2:0) (or
AMPK activity level drops below a threshold (thA~2:0)). For
simplicity we carry out the simulations of the model equations
(11)–(16) in the one-dimensional case. The computational domain
is V~f0vxv1g, and we take Vd~f1{dƒxƒ1g. The glioma
cells begin to migrate into V from the end-point x~0. Glucose is
consumed by tumor cells initially on the left side of the domain
leading to low glucose concentrations near x~0 and relatively
high glucose concentrations in the far field (near x~1).
Simulation results
Figure 7 shows a typical time course of tumor density (n) and
concentrations of ECM (r), MMPs (P), glucose (G), miR-451 (M),
and AMPK (A) in response to a periodic injection of glucose into
the system. Tumor cells were initially located on the left-hand side
of the domain [0,1], near x~0. Glucose is consumed by tumor
cells creating a gradient of glucose with higher levels at more
miR451 and AMPK Mutual Antagonism in Glioma
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levels and high AMPK activity. Tumor cells near the surface of the
tumor mass (with cell density v10%) begin to invade into the
medium (toward the right) through chemotaxis (migration toward
gradient of glucose) and haptotaxis (migration toward gradient of
ECM using MMPs). MMPs are localized near moving front cells,
and the high level of MMPs degrades ECM. This invasion
continues until another flux of glucose is introduced to the system.
Glucose injections at discrete times ½tj,tjzd
0
 , j~1,2,3 (t1~20,
t2~50, t3~80;d
0
~0:01;t~30), then induce a high level of miR-
451 (low AMPK activity) enabling tumor cells in the invasive
region to begin to grow again. One can observe fluctuating miR-
451 levels and AMPK activities in response to glucose levels.
Figure 8 shows a time course of total tumor population and the
levels of glucose, miR-451, and AMPK. Fluctuating glucose levels
in (A) lead to a peak of miR-451 level and low AMPK activity. In
turn, fluctuating AMPK levels give rise to plateau invasion mode
(marked as black arrow in (A)) and creeping growth curve (red
arrow in (A)) of the tumor population due to invading cells near
the tumor surface when the AMPK level is high.
Figure 9 shows that when the total supply of glucose is fixed
t h eg r o w t hr a t eo ft h et u m o rw i t hg l u c o s ef l u c t u a t i o n( b l a c k
solid line) is larger than one with fixed supply of glucose (dotted
black line).
In Figure 10, we show the effect of inhibition strength (a)o f
miR-451 by the AMPK complex (more specifically, by the LKB1/
STRAD complex; see Figure 2A) on the tumor population. In
contrast to the control case (marked as star (*)), the tumor
population does not fluctuate (Figure 10A) and shows slower
growth as a is decreased. Lower values of inhibition strength a
mean higher levels of miR-451 which induce low AMPK activity
in Figure 10B. Blocking miR-451 along the pathways from
CAB39/LKB1/STRAD/AMPK to miR-451 could be therefore a
possible therapeutic target.
Table 2. Parameters used in the tumor model.
Description Dimensional value Dimensionless Refs
Diffusion coefficients
Dn tumor cell in spherical core 10{11 cm2=s 1:6|10{4 [8]
DP MMPs 5|10{11 cm2=s 1:8|10{5 [8,15,16]
DG Glucose 2:31|10{7 cm2=s 8:32|10{2 [8,17],TW
Production/consumption rates
l11 tumor cell growth rate 1:112|10{4 s{1 0.1 [18,19], TW
n0 carrying capacity of tumor cells =n  1.0 TW
l21 ECM degradation rate 1:41|103 cm3g{1s{1 0.508 [8],TW
l22 ECM release/reconstruction rate 5:0|10{5s{1 0.18 [8],TW
r0 ECM carrying capacity =r  1.0 [8]
l31 MMP producdtion rate 6:95|10{5cm3g{1s{1 2.5 TW
l32 MMP decay rate 5:0|10{5s{1 0.18 [8],TW
l41 glucose consumption rate 0:3cm3=(g:s). 1.0 [19,20], TW
l42 glucose injection rate (1:25|10{6{3:75|
10{5)g=(cm3:s)
1–30 TW
Movement parameters (chemotaxis, haptotaxis)
xn chemotactic sensitivity parameter 1:86|10{7 cm5g{1s{1 3:0|10{4 TW
x1
n haptotactic parameter 4:17|10{5 cm5=(g:s) 1:5|10{2 [8],TW
doi:10.1371/journal.pone.0028293.t002
Table 3. Reference variables used in the model.
Var Description Value Refs.
T Time 1 h
L Length 1.0 mm
d glucose injection domain 0.08 mm TW
d
0 injection duration 0.01 h TW
n  tumor cell density 1|10{3 g=cm3 TW
r  ECM density 1:0|10{3 g=cm3 [8,21,22]
P  MMP concentration 1|10{7 g=cm3 [8,23]
G  Glucose concentration 4:5|10{3 g=cm3 [2,19,24]
doi:10.1371/journal.pone.0028293.t003
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AMPK complex by miR-451 on the tumor population. In contrast
to the control case (marked as star (*)), the tumor population does
not show invasion-growth patterns (Figure 11) for large b value
and shows slower growth as b is increased. For intermediate values
of b~1:2, periodic fluctuation of AMPK is observed but the
duration of high AMPK level is not as long as on the case of the
control (b~1:0). We also see, in the case of b~1:2, shorter
invasion periods and slower growth than in the control case.
Higher values of inhibition strength b mean lower AMPK activity
(in Figure 11B) which also induces high values of miR-451 and a
much smaller tumor population. So, increasing inhibition of
AMPK by miR-451 would have the same effect as decreasing
inhibition of miR-451 by the AMPK pathway, and this suggests
another possible therapeutic target.
In Figure 12, we show the time evolution of tumor population
and total concentrations of AMPK and miR-451 for different
values of injection period (t) and injection amount (l42). In the
case of larger amounts of injection (red; l42 =30), the overall
tumor population grows faster than the smaller injection amount
cases (black; l42 =5). In the case of smaller amounts of injection,
the low glucose level (t=50) induces constant invasion without
growth phase (black dotted line). In comparison, the frequent
injection of glucose (t=10) into the system creates a growth-
invasion pattern. However, when the glucose is introduced into the
system every ten hours (t=10), the system (of glucose and tumor
cells) undergoes only three cycles of invasion and growth in
100 hours. This could be explained by the low miR-451
concentrations and high AMPK activity in Figure 12. In the case
of larger amounts of glucose injected (l42 =30), frequent injection
leads to monotone growth phase while less frequent but
appropriately small amounts of glucose injection lead to faster
growth through cycles of invasion and growth. In the former case,
as one can see in low AMPK concentration, tumor cells spend
most of their time in growth phase due to abundant glucose with
frequent large amounts of glucose injection. In the latter case, we
also note that the number of the injections matches with the
corresponding cycle, i.e. the system adapts to the growth-invasion
phase each time glucose was administered. This dynamic behavior
can also be confirmed in highly dynamic fluctuations in
concentrations of miR-451 and AMPK.
Discussion
Glioblastoma cancer cells shift their metabolic machinery
toward a high level of glucose uptake, a phenomenon called the
Figure 7. Typical evolution of spatial profiles of tumor density (n) and concentrations of ECM (r), MMPs (P), glucose (G), miR-451
(M), and AMPK (A). In each subfigure x-axis indicates the computational domain, left end (x~0) being the center of tumor mass and right end
(x~1) being the farthest field away from the tumor. Glucose was provided on the right hand side of the domain near x~1 and glucose is transported
by diffusion. Injection of glucose (G~20) was given on the right side of domain (0:92ƒxƒ1:0) at time t~20,50,80. Levels of miR-451 and AMPK
change in response to fluctuating glucose and determine whether cells would invade or grow. The red dotted line (2.) indicates the threshold
thM~2:0.
doi:10.1371/journal.pone.0028293.g007
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to migrate in the direction of abundant glucose levels. Thus, the
cancer cells migrate in the direction of increased glucose sources.
Godlewski et al. [2] demonstrated that under low glucose levels
glioma cells downregulate miR-451, and that this leads to
upregulation of the AMPK kinases, which in turn increases the
migration of cells while reducing their proliferation and growth.
On the other hand, under normal (high) glucose levels, miR-451 is
upregulated, leading to decreased AMPK activity, which results in
elevated proliferation and growth but reduced migration.
In the present paper we developed a mathematical model of
glioma cell migration and proliferation. In this paper, we
considered the important role that miR-451 plays in glioblastoma.
The model includes the concentrations of cancer cells, ECM,
MMP, glucose, miR-451 and AMPK. Simulation of the model
shows that by changing the level of glucose through periodic
injections of glucose, the cancer cells will undergo nearly periodic
changes from migration to proliferation modes. We showed how
the effects of glucose on cells need to be ‘‘refined’’ by taking into
account the recent history of glucose variations. The simulations
show how variations in glucose significantly affect the level of miR-
451 and, in turn, cell migration. The model predicts that
oscillations in the levels of glucose increase the growth of the
Figure 8. Dynamics of tumor invasion/growth. (A) Time evolution
of total tumor population and total glucose level. Cells adapt growth
phase (red arrows) via low AMPK level (high miR-451) when glucose
supply is high and invasive phase (black arrows) via high AMPK level
(low miR-451) in response to low glucose levels. (B) Time evolution of
total concentrations of miR-451 and AMPK. High peaks of miR-451 are
consistent with high peaks of glucose in (A) and lead to low levels of
AMPK. *Data from Figure 7.
doi:10.1371/journal.pone.0028293.g008
Figure 9. Comparison of tumor growth. Time evolution of total
tumor population and total glucose level near far away field. In
responds to periodic input of high glucose, tumor population shows
alternating growth and invasion pattern (solid;black). When same
amount of glucose without glucose fluctuation was provided to the
system near x~1, tumor population growth is induced from diffused
glucose level and followed high miR-451 and low AMPK concentration
at cell site. This induces a low chance of cell invsion near the surface
and eventually total growth is low compared to the case with
fluctuating glucose level.
doi:10.1371/journal.pone.0028293.g009
Figure 10. Effect of inhibition strength (a) of miR-451 by AMPK.
(A–B) Time evolution of tumor population and AMPK concentration
within the system for different values of a~1:6,1:2,0:16. The control
case was marked as star (*) for each subfigure.
doi:10.1371/journal.pone.0028293.g010
Figure 11. Effect of inhibition strength (b) of AMPK by miR-451.
(A–B) Time evolution of tumor population and AMPK concentration
within the system for different values of b~1:0,1:2,10. The control case
was marked as star (*) for each subfigure.
doi:10.1371/journal.pone.0028293.g011
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upregulate miR-451, or block other components of the CAB39/
AMPK pathway, will slow down glioma cell migration. In
summary, the conclusions from the model include:
(i) Fluctuating glucose can lead to faster tumour growth and
spread
(ii) Response depends on the previous glucose levels, i.e.,
whether it is rising or falling
(iii) Targeting this pathway may reduce tumour growth by
disrupting the cyclic responses to fluctuating glucose.
We suggest these simulation results as hypotheses to be tested
experimentally. If the predictions of the model can be confirmed
experimentally, we could proceed, side-by-side with the model and
with experiments to determine how by modulating the injection of
glucose, upregulating miR-451 (decreasing the a inhibition) and
downregulating LKB1/STRAD (increasing the b inhibition) we
can decrease the invasion and the overall growth of the tumor.
Simulations suggest that targeting this pathway may be beneficial
in GBM treatments.
In this paper we used the concentration of tumor cells, not
individual cells. Since even an isolated migrating glioblastoma cell
may lead to faster spread and recurrence after surgery, it would be
important to extend our paper by introducing cancer cells as
individual agents. Hybrid approach will include cancer cells as
individuals but the various chemical species as concentrations. A
hybrid approach [10] has been proven to be important and useful
in order to better understand the detailed mechanical interaction
between a tumor cell and its microenvironment (see a recent
review [11]). For simplicity we did not include in our model some
important components of the microenvironment that may affect
the growth and migration of glioma, notably fibroblasts,
endothelial cells, and immune cells, as well as cytokines and
growth factors secreted by these cells. There is currently only a
limited understanding of the complex relationship between the
tumor cells and the host cells in the microenvironment. A better
understanding of this relationship may lead to new therapeutic
approaches that target stromal elements instead of, or in addition
to, tumor cells. We hope to address these situations in future work.
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